<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">ScientificWorldJournal</journal-id><journal-id journal-id-type="iso-abbrev">ScientificWorldJournal</journal-id><journal-id journal-id-type="publisher-id">TSWJ</journal-id><journal-title-group><journal-title>The Scientific World Journal</journal-title></journal-title-group><issn pub-type="ppub">2356-6140</issn><issn pub-type="epub">1537-744X</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">23766705</article-id><article-id pub-id-type="pmc">3674688</article-id><article-id pub-id-type="doi">10.1155/2013/703568</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Alternative Splicing for Diseases, Cancers, Drugs, and Databases</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">0000-0002-5690-0708</contrib-id><name><surname>Tang</surname><given-names>Jen-Yang</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jin-Ching</given-names></name><xref ref-type="aff" rid="I4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hou</surname><given-names>Ming-Feng</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="I5">
<sup>5</sup>
</xref><xref ref-type="aff" rid="I6">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Chun-Lin</given-names></name><xref ref-type="aff" rid="I7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Chien-Chi</given-names></name><xref ref-type="aff" rid="I7">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Hurng-Wern</given-names></name><xref ref-type="aff" rid="I8">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">0000-0002-2060-224X</contrib-id><name><surname>Chang</surname><given-names>Hsueh-Wei</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="I9">
<sup>9</sup>
</xref><xref ref-type="aff" rid="I10">
<sup>10</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Radiation Oncology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><aff id="I2"><sup>2</sup>Department of Radiation Oncology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan</aff><aff id="I3"><sup>3</sup>Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><aff id="I4"><sup>4</sup>Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><aff id="I5"><sup>5</sup>Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><aff id="I6"><sup>6</sup>Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung 807, Taiwan</aff><aff id="I7"><sup>7</sup>Bioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu 300, Taiwan</aff><aff id="I8"><sup>8</sup>Institute of Biomedical Science, National Sun Yat-Sen University, Kaohsiung 807, Taiwan</aff><aff id="I9"><sup>9</sup>Graduate Institute of Natural Products, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><aff id="I10"><sup>10</sup>Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung 807, Taiwan</aff><author-notes><corresp id="cor1">*Hsueh-Wei Chang: <email>changhw2007@gmail.com</email></corresp><fn fn-type="other"><p>Academic Editors: F. Alvarez-Valin and A. Komiya</p></fn></author-notes><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>22</day><month>5</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>703568</elocation-id><history><date date-type="received"><day>1</day><month>4</month><year>2013</year></date><date date-type="accepted"><day>30</day><month>4</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Jen-Yang Tang et al.</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Alternative splicing is a major diversification mechanism in the human transcriptome and proteome. Several diseases, including cancers, have been associated with dysregulation of alternative splicing. Thus, correcting alternative splicing may restore normal cell physiology in patients with these diseases. This paper summarizes several alternative splicing-related diseases, including cancers and their target genes. Since new cancer drugs often target spliceosomes, several clinical drugs and natural products or their synthesized derivatives were analyzed to determine their effects on alternative splicing. Other agents known to have modulating effects on alternative splicing during therapeutic treatment of cancer are also discussed. Several commonly used bioinformatics resources are also summarized.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction to Alternative Splicing</title><p>Alternative splicing of RNA is a key mechanism of increasing complexity in mRNA and proteins [<xref rid="B1" ref-type="bibr">1</xref>]. Since alternative splicing apparently controls almost all human gene activities, imbalances in the this splicing process may affect the progression of various human diseases and cancers [<xref rid="B2" ref-type="bibr">2</xref>]. Varying alternations in excision and/or inclusion of exons may generate different mRNA transcripts and corresponding proteins. Therefore, in addition to mediating changes in protein structure, function, and localization [<xref rid="B3" ref-type="bibr">3</xref>], alternative splicing in higher eukaryotes affects the differentiation and development of cancer and other diseases [<xref rid="B4" ref-type="bibr">4</xref>].</p></sec><sec id="sec2"><title>2. Alternative Splicing and Diseases</title><p>Alternative RNA splicing is commonly reported in neurological and muscle diseases [<xref rid="B5" ref-type="bibr">5</xref>&#x02013;<xref rid="B7" ref-type="bibr">7</xref>]. Studies show that these diseases at least partly result from alternative splicing, which regulates the complexity of integral membrane proteins, including changes in their topology, solubility, and signal peptides [<xref rid="B3" ref-type="bibr">3</xref>]. For example, aberrant alternative splicing has shown associations with Parkinson disease [<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B8" ref-type="bibr">8</xref>]. For spinal muscular atrophy (SMA), the level of survival motor neuron (SMN) protein was downregulated by its alternative splicing [<xref rid="B9" ref-type="bibr">9</xref>]. Therapies for SMA have recently improved by targeting RNA splicing for inclusion of exon 7 into SMN mRNA [<xref rid="B10" ref-type="bibr">10</xref>]. Phorbol 12-myristate 13-acetate was reported to modulate the alternative splicing of sarcoplasmic reticulum Ca<sup>2+</sup>-ATPase1 (SERCA1) which is dysregulated in myotonic dystrophy type 1 disease [<xref rid="B11" ref-type="bibr">11</xref>].</p><p>Additionally, alternative splicing reportedly regulates heart development [<xref rid="B12" ref-type="bibr">12</xref>], cardiovascular disease [<xref rid="B13" ref-type="bibr">13</xref>], blood coagulation [<xref rid="B14" ref-type="bibr">14</xref>], cholesterol homeostasis [<xref rid="B15" ref-type="bibr">15</xref>], cellular proliferation, apoptosis, immunity [<xref rid="B16" ref-type="bibr">16</xref>], and systemic sclerosis [<xref rid="B17" ref-type="bibr">17</xref>]. For example, heart-specific knockout of the serine/arginine- (SR-) rich family of splicing factors, ASF/SF2, produces cardiomyopathy and affects splicing of cardiac troponin T and LIM domain-binding protein [<xref rid="B18" ref-type="bibr">18</xref>]. Specific CLK inhibitors (dichloroindolyl enaminonitrile KH-CB19) of CDC2-like kinase isoforms 1 and 4 (CLK1/CLK4) can inhibit phosphorylation of cellular SR splicing factors and affect the splicing of tissue factor isoforms flTF (full-length TF) and asHTF (alternatively spliced human TF) [<xref rid="B19" ref-type="bibr">19</xref>].</p><p>Using exon array, the global mRNA splicing profile of ischemic cardiomyopathy has been investigated, and the alternative splicing of four main sarcomere genes, such as cardiac troponin T (TNNT2), cardiac troponin I (TNNI3), myosin heavy chain 7 (MYH7), and filamin C, gamma (FLNC), was dysregulated [<xref rid="B20" ref-type="bibr">20</xref>]. The alternative splicing of blood coagulation-related genes including tissue factor (coagulation factor III), tissue factor pathway inhibitor (TFPI), and coagulation factor XI has been well reviewed [<xref rid="B14" ref-type="bibr">14</xref>]. For cholesterol production and uptake, alternative splicing of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) and LDL receptor (LDLR) can suppress their protein activities [<xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B22" ref-type="bibr">22</xref>]. Proprotein convertase subtilisin/kexin type 9 (PCSK9) [<xref rid="B23" ref-type="bibr">23</xref>], HMG-CoA synthase (HMGCS1) [<xref rid="B24" ref-type="bibr">24</xref>], and mevalonate kinase [<xref rid="B25" ref-type="bibr">25</xref>] also reported to be involved in cholesterol biosynthesis and receptor-mediated uptake through alternative splicing.</p></sec><sec id="sec3"><title>3. Alternative Splicing and Cancer</title><p>In cancer-associated genes, splicing has important roles in oncogenesis, tumor suppression [<xref rid="B26" ref-type="bibr">26</xref>], and metastasis [<xref rid="B27" ref-type="bibr">27</xref>]. Alterations in alternative splicing are commonly reported in various cancers [<xref rid="B27" ref-type="bibr">27</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>]. Reported examples include p53 and PTEN [<xref rid="B30" ref-type="bibr">30</xref>], kallikrein-related peptidase 12 (KLK12) [<xref rid="B31" ref-type="bibr">31</xref>], breast cancer early-onset 1 (BRCA1) [<xref rid="B32" ref-type="bibr">32</xref>], protein N-arginine methyltransferases 2 (PRMT2) [<xref rid="B33" ref-type="bibr">33</xref>], and CDC25 phosphatases [<xref rid="B34" ref-type="bibr">34</xref>] in breast cancer; lysyl oxidase-like 4 (LOXL4) [<xref rid="B35" ref-type="bibr">35</xref>] and growth factor receptor-bound protein 7 (GRB7) in ovarian cancer [<xref rid="B36" ref-type="bibr">36</xref>]; androgen receptor in prostate cancer [<xref rid="B37" ref-type="bibr">37</xref>]; tissue inhibitor of metalloproteinases-1 (TIMP1) and the cell adhesion molecule CD44 in colon cancer [<xref rid="B38" ref-type="bibr">38</xref>, <xref rid="B39" ref-type="bibr">39</xref>]; Bcl-xL, CD44, and others in lung cancer [<xref rid="B40" ref-type="bibr">40</xref>]; calpain 3 in melanoma [<xref rid="B41" ref-type="bibr">41</xref>]; and Kr&#x000fc;ppel-like factor 6 (KLF6) in liver cancer [<xref rid="B42" ref-type="bibr">42</xref>]. Therefore, alternative spliced variants are potential biomarkers [<xref rid="B43" ref-type="bibr">43</xref>, <xref rid="B44" ref-type="bibr">44</xref>] for the cancer diagnosis/prognosis and may be the targets for cancer therapy based on specific splicing correction treatments.</p><p>Single nucleotide polymorphisms (SNPs) affecting exon skipping has reviewed to confer to complex diseases [<xref rid="B45" ref-type="bibr">45</xref>]. The improvement of high-throughput technologies such as RNA-Seq [<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B47" ref-type="bibr">47</xref>] and exon arrays [<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>] is helpful to identify the genome-wide cancer-associated splicing variants. Splicing changes may associate with lung and prostate cancer risk in terms of some SNPs. For example, a coding synonymous SNP G870A of cyclin D1 (CCND1) with a modulating ability to its splice pattern was reported to be associated with lung cancer susceptibility [<xref rid="B50" ref-type="bibr">50</xref>]. Similarly, some coding synonymous SNPs may generate new splicing sites in the middle of an exon of p53 gene to change splicing [<xref rid="B51" ref-type="bibr">51</xref>]. Mutations in the adenomatous polyposis coli (APC) [<xref rid="B52" ref-type="bibr">52</xref>] and BRCA1 [<xref rid="B53" ref-type="bibr">53</xref>, <xref rid="B54" ref-type="bibr">54</xref>] genes have reported to skip exon by altering splicing. Furthermore, an intronic SNP, IVS &#x02212;27&#x02009;G&#x0003e;A/IVS&#x00394;A, creates a new splicing factor SR-binding site and deletes two other overlapping SR-binding sites, generating three alternative splicing forms of KLF6 (KLF6 SV1-3) [<xref rid="B55" ref-type="bibr">55</xref>]. This SNP was found to be associated with prostate cancer [<xref rid="B56" ref-type="bibr">56</xref>]. For lung cancer study, the tumor patients with overexpression of KLF6 SV1 have lower survival [<xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B57" ref-type="bibr">57</xref>].</p><p>Actually, the information of many SNPs located in 3&#x02032; and 5&#x02032; splicing sites is searchable in the dbSNP in NCBI website (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/snp">http://www.ncbi.nlm.nih.gov/snp</ext-link>) when the &#x0201c;limit&#x0201d; function is chosen. Researchers may choose the SNPs of splicing sites located in interested genes to identify their association relationships to diseases and cancers. A database consisting of genome-wide SNP and splicing sites, namely, ssSNPTarget [<xref rid="B58" ref-type="bibr">58</xref>] was designed to search the splice site SNPs (ssSNPs) by input of gene symbol, SNP rs number, transcript ID, or genomic position (<ext-link ext-link-type="uri" xlink:href="http://variome.kobic.re.kr/ssSNPTarget/">http://variome.kobic.re.kr/ssSNPTarget/</ext-link>).</p></sec><sec id="sec4"><title>4. Alternative Splicing-Related Drugs and Natural Products</title><p>Splice modulating therapies have been developed for human disease [<xref rid="B59" ref-type="bibr">59</xref>&#x02013;<xref rid="B61" ref-type="bibr">61</xref>] and cancer therapy [<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>]. Antitumor drugs have been developed to target alternative splicing [<xref rid="B64" ref-type="bibr">64</xref>], splice variants [<xref rid="B65" ref-type="bibr">65</xref>], and spliceosomes [<xref rid="B66" ref-type="bibr">66</xref>, <xref rid="B67" ref-type="bibr">67</xref>]. For example, pharmacological interventions may be affected by mRNA transcript diversity [<xref rid="B68" ref-type="bibr">68</xref>]. To correct aberrant splicing, specific mRNA transcripts have been targeted in genetic disorders such as Duchenne muscular dystrophy. Since mutations of splicing factor 3B subunit 1 (SF3B1) are common in several haematological malignancies, the use of various natural products and their synthetic derivatives in therapies targeting SF3B has proven highly effective [<xref rid="B67" ref-type="bibr">67</xref>].</p><p>For drug discovery for SMA, several small molecules including sodium vanadate [<xref rid="B69" ref-type="bibr">69</xref>], aclarubicin [<xref rid="B70" ref-type="bibr">70</xref>], and indoprofen [<xref rid="B71" ref-type="bibr">71</xref>], hydroxyurea [<xref rid="B72" ref-type="bibr">72</xref>], valproate [<xref rid="B73" ref-type="bibr">73</xref>], 5-(N-ethyl-N-isopropyl)-amiloride (EIPA) [<xref rid="B74" ref-type="bibr">74</xref>], and phenylbutyrate [<xref rid="B75" ref-type="bibr">75</xref>] that increases inclusion of exon 7 of SMN2 gene have been identified, although some of them may have side effects. Recently, novel phosphatase modulators, namely, pseudocantharidins have been discovered with the similar regulating function to SMN splicing [<xref rid="B76" ref-type="bibr">76</xref>]. Valproic acid was found to enhance SMN2 expression in SMA cell model involving the SF2/ASF and hnRNPA1 [<xref rid="B77" ref-type="bibr">77</xref>].</p><p>Clinical drugs such as novantrone (mitoxantrone) can enhance the effectiveness of therapeutic treatments for familial neurodegenerative diseases by stabilizing the tau pre-mRNA splicing regulatory element [<xref rid="B78" ref-type="bibr">78</xref>]. Tamoxifen has proven effective for clinical treatment of estrogen receptor- (ER-) positive breast cancer [<xref rid="B79" ref-type="bibr">79</xref>]. In endometrial cancer cells, alternative splicing of ER involving ER-alpha36 is also known to enhance the agonist activity of tamoxifen [<xref rid="B80" ref-type="bibr">80</xref>].</p><p>Natural products, including many xenobiotics, are also known to impair alternative splicing [<xref rid="B81" ref-type="bibr">81</xref>]. For example, natural products such as pladienolide B and FR901464 [<xref rid="B82" ref-type="bibr">82</xref>, <xref rid="B83" ref-type="bibr">83</xref>] are known to affect spliceosome function. However, the synthesis of these compounds is complicated by their multiple stereocenters. A recent study synthesized Sudemycins, which are novel analogues of FR901464. By inducing alternative gene splicing, the Sudemycins conferred both <italic>in vitro </italic>and <italic>in vivo</italic> antitumor effects [<xref rid="B84" ref-type="bibr">84</xref>]. Alternative splicing has also shown regulating effects on the antitumor drug Spliceostatin A, a stabilized derivative of a <italic>Pseudomonas</italic> bacterial fermentation product [<xref rid="B85" ref-type="bibr">85</xref>] which specifically targets the SF3b spliceosome subcomplex to inhibit pre-mRNA splicing [<xref rid="B86" ref-type="bibr">86</xref>]. Meayamycin, an analogue of the natural antitumor product FR901464 [<xref rid="B87" ref-type="bibr">87</xref>], inhibits RNA splicing against multidrug-resistant cells and performs antiproliferative effect against human breast cancer MCF-7 cells by suppression of alternative splicing [<xref rid="B88" ref-type="bibr">88</xref>]. These results suggest that, because of their modulating effects on RNA splicing, xenobiotic analogs have potential use as chemical probes and as anticancer agents. Similarly, the polyketide natural product borrelidin inhibits cancer metastasis by modulating alternative splicing in VEGF [<xref rid="B89" ref-type="bibr">89</xref>]. Antitumor effects involving alternative splicing [<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>] have also been reported in natural dietary products. For example, resveratrol can modulate exon inclusion of SRp20 and SMN2 pre-mRNAs and induce the expression of processing factors of alternative splicing such as ASF/SF2, hnRNPA1, and HuR [<xref rid="B92" ref-type="bibr">92</xref>].</p><p>Recent studies have investigated the role of splice variants in apoptotic pathways [<xref rid="B93" ref-type="bibr">93</xref>, <xref rid="B94" ref-type="bibr">94</xref>]. Regulation of alternative splicing genes may have anticancer effects. For example, BCL-X<sub>s</sub> and BCL-X<sub>L</sub> have been associated with proapoptotic and antiapoptotic effects, respectively, during the progression of cancer [<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B95" ref-type="bibr">95</xref>, <xref rid="B96" ref-type="bibr">96</xref>]. The ratio of BCL-X<sub>s</sub>/BCL-X<sub>L</sub> can be decreased by the treatment of protein kinase C (PKC) inhibitor and apoptotic inducer staurosporine in 293 cells [<xref rid="B97" ref-type="bibr">97</xref>]. Soluble and membrane-bound forms of TNF receptor superfamily, member 6 (FAS) containing exons 5/7 and 5/6/7 also display proapoptotic and antiapoptotic effects, respectively [<xref rid="B67" ref-type="bibr">67</xref>]. The caspase 9 (CASP9) gene has two antagonistic isoforms, proapoptotic Casp9a and prosurvival Casp9b, and its splicing is dysregulated in NSCLC lung cancer cell lines [<xref rid="B98" ref-type="bibr">98</xref>].</p><p>Alternative splicing is regulated by chromatin structure and histone modifications [<xref rid="B4" ref-type="bibr">4</xref>]. In thyroid tumor cells, for example, histone deacetylase inhibitors such as butyrate modulate transcription and alternative splicing of prohibitin [<xref rid="B99" ref-type="bibr">99</xref>]. A study of bovine epithelial cells showed that butyrate, a major metabolite generated by bacterial fermentation of dietary fiber in colon cells, has regulating effects on apoptosis and cell proliferation through alternative splicing [<xref rid="B100" ref-type="bibr">100</xref>]. Since histone deacetylase inhibitor may have antitumor effects, the identification of this kind of inhibitor in natural products can improve drug development for tumor therapy. </p></sec><sec id="sec5"><title>5. Alternative Splicing-Related Bioinformatics Resources</title><p>Several bioinformatics analyses for the detection and regulation of alternative splicing have been well reviewed [<xref rid="B101" ref-type="bibr">101</xref>&#x02013;<xref rid="B103" ref-type="bibr">103</xref>]. However, these literatures mainly focused on the methodology for detection of alternative splicing, and the databases of alternative splicing are less addressed and summarized. Here, we collect several helpful bioinformatics resources related to alternative splicing as shown in <xref ref-type="table" rid="tab1">Table 1</xref>.</p><p> For example, AsMamDB [<xref rid="B104" ref-type="bibr">104</xref>] is one of the early established alternative splice databases of mammals, although their websites are not functional currently. PALS db [<xref rid="B105" ref-type="bibr">105</xref>] provides the putative alternative splicing database based on UniGene clusters of human and mouse sources which mainly consist of EST data. Similarly, some databases such as EASED [<xref rid="B106" ref-type="bibr">107</xref>] and AVATAR [<xref rid="B107" ref-type="bibr">108</xref>] are constructed by datasets of EST and mRNAs. ASAP [<xref rid="B108" ref-type="bibr">106</xref>] provides the detail annotation for exon-intron boundary, alternative splicing, and its tissue specificity for the user to design probes for distinguishing different splicing isoforms. MAASE [<xref rid="B109" ref-type="bibr">109</xref>] is also specifically designed to apply in splicing microarray experiments. In contrast, Splicy [<xref rid="B110" ref-type="bibr">115</xref>] provide the web-based tool to predict possible alternative splicing events from Affymetrix probe set inputs. ASTALAVISTA [<xref rid="B111" ref-type="bibr">116</xref>] provides alternative splicing prediction for transcriptome data from GENCODE, REFSEQ, and ENSEMBL as well as from custom gene datasets. Furthermore, SpliceCenter [<xref rid="B112" ref-type="bibr">120</xref>] is a web server for predicting the influence of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based data.</p><p>Both PolyA_DB [<xref rid="B113" ref-type="bibr">110</xref>] and AltTrans provide the information for alternative polyadenylation [<xref rid="B114" ref-type="bibr">111</xref>]. For AltTrans, the AltSplice pipeline on splicing and the AltPAS pipeline on polyadenylation were implemented. ASTD [<xref rid="B115" ref-type="bibr">126</xref>] also provides the variants for splicing, transcription initiation, and polyadenylation. Of note, the dataset of transcriptomics for alternative splicing is larger than for alternative polyadenylation. GRSDB [<xref rid="B116" ref-type="bibr">112</xref>] is a mammalian database of alternative splicing based on quadruplex forming G-rich sequences which modulate the 3&#x02032; end processing of pre-mRNAs.</p><p>Additionally, several comprehensive databases for alternative splicing have been developed such as HOLLYWOOD [<xref rid="B117" ref-type="bibr">113</xref>], ASD [<xref rid="B118" ref-type="bibr">114</xref>], BIPASS [<xref rid="B119" ref-type="bibr">117</xref>], ECgene [<xref rid="B120" ref-type="bibr">118</xref>], ASPicDB [<xref rid="B121" ref-type="bibr">121</xref>], AspAlt [<xref rid="B122" ref-type="bibr">125</xref>], H-DBAS [<xref rid="B123" ref-type="bibr">128</xref>], SPLOOCE [<xref rid="B124" ref-type="bibr">129</xref>], and APPRIS [<xref rid="B125" ref-type="bibr">130</xref>]. For example, the ECgene provides EST and serial analysis of gene expression (SAGE) data-based annotation and visualization for alternative splicing (AS). The ASPicDB provides EST-based tissue-specific splicing information of normal and cancer cells. The H-DBAS provides alternative splicing annotation based on RNA-Seq transcriptomics data. The APPRIS provides the annotation for principal isoform as the standard reference sequence for each gene.</p><p>Some resources of alternative splicing have special features such as splice signals in EuSplice [<xref rid="B126" ref-type="bibr">119</xref>], tandem splice sites in TassDB2 [<xref rid="B127" ref-type="bibr">127</xref>], mutational evidence-based analysis in Alternative Splicing Mutation Database [<xref rid="B128" ref-type="bibr">122</xref>], splicing proteins in SpliceAid 2 [<xref rid="B129" ref-type="bibr">131</xref>], and transcription factors in TFClass [<xref rid="B130" ref-type="bibr">132</xref>]. However, the impacts of alternative splicing on the spliced transcripts encoded protein structure are less addressed. Some databases such as ProSAS [<xref rid="B131" ref-type="bibr">123</xref>] and SpliVaP [<xref rid="B132" ref-type="bibr">124</xref>] also provide the protein isoforms from the alternative splicing effects. In ProSAS, the protein isoforms of splicing transcripts are annotated in Ensembl or SwissProt. In SpliVap, protein signatures of alternative forms are annotated in terms of Pfam domains and PRINTS fingerprints.</p></sec><sec id="sec6"><title>6. Conclusion</title><p>Accumulating evidence shows that alternative splicing can be selectively targeted in several genes of cancer cells. An exciting possibility raised by this study is that the effectiveness of anticancer therapies may be enhanced by clinical drugs, natural products, and their synthesized analogs that target alternative splicing machinery. Some alternative splicing-related databases and web servers may also helpful to improve the alternative splicing therapy for treating cancer and other diseases.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was supported by Grants from the National Science Council (NSC101-2320-B-037-049), the Department of Health, Executive Yuan, China (DOH102-TD-C-111-002), the Technology Development Programs, Ministry of Economic Affairs, Taiwan (102-EC-17-A-01-04-0525), the Kaohsiung Medical University Research Foundation (KMUER001), and the National Sun Yat-Sen University-KMU Joint Research Project (no. NSYSU-KMU 102-034).</p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brett</surname><given-names>D</given-names></name><name><surname>Pospisil</surname><given-names>H</given-names></name><name><surname>Valc&#x000e1;rcel</surname><given-names>J</given-names></name><name><surname>Reich</surname><given-names>J</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name></person-group><article-title>Alternative splicing and genome complexity</article-title><source><italic>Nature Genetics</italic></source><year>2002</year><volume>30</volume><issue>1</issue><fpage>29</fpage><lpage>30</lpage><pub-id pub-id-type="other">2-s2.0-0036338127</pub-id><pub-id pub-id-type="pmid">11743582</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghigna</surname><given-names>C</given-names></name><name><surname>De Toledo</surname><given-names>M</given-names></name><name><surname>Bonomi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives</article-title><source><italic>RNA Biology</italic></source><year>2010</year><volume>7</volume><issue>4</issue><fpage>495</fpage><lpage>503</lpage><pub-id pub-id-type="other">2-s2.0-77957302252</pub-id><pub-id pub-id-type="pmid">20864806</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittendorf</surname><given-names>KF</given-names></name><name><surname>Deatherage</surname><given-names>CL</given-names></name><name><surname>Ohi</surname><given-names>MD</given-names></name><name><surname>Sanders</surname><given-names>CR</given-names></name></person-group><article-title>Tailoring of membrane proteins by alternative splicing of pre-mRNA</article-title><source><italic>Biochemistry</italic></source><year>2012</year><volume>51</volume><issue>28</issue><fpage>5541</fpage><lpage>5556</lpage><pub-id pub-id-type="pmid">22708632</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luco</surname><given-names>RF</given-names></name><name><surname>Allo</surname><given-names>M</given-names></name><name><surname>Schor</surname><given-names>IE</given-names></name><name><surname>Kornblihtt</surname><given-names>AR</given-names></name><name><surname>Misteli</surname><given-names>T</given-names></name></person-group><article-title>Epigenetics in alternative pre-mRNA splicing</article-title><source><italic>Cell</italic></source><year>2011</year><volume>144</volume><issue>1</issue><fpage>16</fpage><lpage>26</lpage><pub-id pub-id-type="other">2-s2.0-78650961149</pub-id><pub-id pub-id-type="pmid">21215366</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulos</surname><given-names>MG</given-names></name><name><surname>Batra</surname><given-names>R</given-names></name><name><surname>Charizanis</surname><given-names>K</given-names></name><name><surname>Swanson</surname><given-names>MS</given-names></name></person-group><article-title>Developments in RNA splicing and disease</article-title><source><italic>Cold Spring Harbor Perspectives in Biology</italic></source><year>2011</year><volume>3</volume><issue>1</issue><pub-id pub-id-type="publisher-id">a000778</pub-id><pub-id pub-id-type="other">2-s2.0-79960627395</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>JD</given-names></name><name><surname>Janitz</surname><given-names>M</given-names></name></person-group><article-title>Alternative splicing of mRNA in the molecular pathology of neurodegenerative diseases</article-title><source><italic>Neurobiology of Aging</italic></source><year>2012</year><volume>33</volume><issue>5</issue><fpage>1011</fpage><lpage>1024</lpage></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>K</given-names></name><name><surname>Makeyev</surname><given-names>EV</given-names></name></person-group><article-title>Regulation of gene expression in mammalian nervous system through alternative pre-mRNA splicing coupled with RNA quality control mechanisms</article-title><source><italic>Molecular and Cellular Neuroscience</italic></source><year>2013</year></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>RH</given-names></name><name><surname>Liu</surname><given-names>SP</given-names></name><name><surname>Huang</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Aberrant alternative splicing events in Parkinson's disease</article-title><source><italic>Cell Transplantation</italic></source><year>2013</year><volume>22</volume><issue>4</issue><fpage>653</fpage><lpage>661</lpage><pub-id pub-id-type="pmid">23127794</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearn</surname><given-names>J</given-names></name></person-group><article-title>Classification of spinal muscular atrophies</article-title><source><italic>Lancet</italic></source><year>1980</year><volume>1</volume><issue>8174</issue><fpage>919</fpage><lpage>922</lpage><pub-id pub-id-type="other">2-s2.0-0018906764</pub-id><pub-id pub-id-type="pmid">6103267</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name></person-group><article-title>Targeting RNA-splicing for SMA treatment</article-title><source><italic>Molecules and Cells</italic></source><year>2012</year><volume>33</volume><issue>3</issue><fpage>223</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">22382684</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Koebis</surname><given-names>M</given-names></name><name><surname>Suo</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Ishiura</surname><given-names>S</given-names></name></person-group><article-title>Regulation of the alternative splicing of <italic>sarcoplasmic reticulum</italic> Ca<sup>2+</sup>-<italic>ATPase1</italic> (<italic>SERCA1</italic>) by phorbol 12-myristate 13-acetate (PMA) via a PKC pathway</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2012</year><volume>423</volume><issue>2</issue><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">22609207</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>TA</given-names></name></person-group><article-title>Alternative splicing regulation impacts heart development</article-title><source><italic>Cell</italic></source><year>2005</year><volume>120</volume><issue>1</issue><fpage>1</fpage><lpage>2</lpage><pub-id pub-id-type="other">2-s2.0-11844281510</pub-id><pub-id pub-id-type="pmid">15652472</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lara-Pezzi</surname><given-names>E</given-names></name><name><surname>Dopazo</surname><given-names>A</given-names></name><name><surname>Manzanares</surname><given-names>M</given-names></name></person-group><article-title>Understanding cardiovascular disease: a journey through the genome (and what we found there)</article-title><source><italic>Disease Models &#x00026; Mechanisms</italic></source><year>2012</year><volume>5</volume><issue>4</issue><fpage>434</fpage><lpage>443</lpage><pub-id pub-id-type="pmid">22730474</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>VY</given-names></name></person-group><article-title>Blood coagulation and alternative pre-mRNA splicing: an overview</article-title><source><italic>Current Molecular Medicine</italic></source><year>2006</year><volume>6</volume><issue>8</issue><fpage>859</fpage><lpage>869</lpage><pub-id pub-id-type="other">2-s2.0-33845361026</pub-id><pub-id pub-id-type="pmid">17168737</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>MW</given-names></name><name><surname>Krauss</surname><given-names>RM</given-names></name></person-group><article-title>Alternative splicing in the regulation of cholesterol homeostasis</article-title><source><italic>Current Opinion in Lipidology</italic></source><year>2013</year><volume>24</volume><issue>2</issue><fpage>147</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">23314925</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo-Umeda</surname><given-names>K</given-names></name><name><surname>Uno</surname><given-names>S</given-names></name><name><surname>Fujimori</surname><given-names>K</given-names></name><etal/></person-group><article-title>Differential expression and function of alternative splicing variants of human liver X receptor alpha</article-title><source><italic>Molecular Pharmacology</italic></source><year>2012</year><volume>81</volume><issue>6</issue><fpage>800</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">22399489</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manetti</surname><given-names>M</given-names></name><name><surname>Guiducci</surname><given-names>S</given-names></name><name><surname>Ibba-Manneschi</surname><given-names>L</given-names></name><name><surname>Matucci-Cerinic</surname><given-names>M</given-names></name></person-group><article-title>Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant</article-title><source><italic>Trends in Cardiovascular Medicine</italic></source><year>2011</year><volume>21</volume><issue>7</issue><fpage>204</fpage><lpage>210</lpage><pub-id pub-id-type="pmid">22867700</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Ding</surname><given-names>JH</given-names></name><etal/></person-group><article-title>ASF/SF2-regulated CaMKII<italic>&#x003b4;</italic> alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle</article-title><source><italic>Cell</italic></source><year>2005</year><volume>120</volume><issue>1</issue><fpage>59</fpage><lpage>72</lpage><pub-id pub-id-type="other">2-s2.0-19944427655</pub-id><pub-id pub-id-type="pmid">15652482</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorov</surname><given-names>O</given-names></name><name><surname>Huber</surname><given-names>K</given-names></name><name><surname>Eisenreich</surname><given-names>A</given-names></name><etal/></person-group><article-title>Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing</article-title><source><italic>Chemistry &#x00026; Biology</italic></source><year>2011</year><volume>18</volume><issue>1</issue><fpage>67</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">21276940</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>SW</given-names></name><name><surname>Hu</surname><given-names>YW</given-names></name><name><surname>Ho</surname><given-names>JWK</given-names></name><etal/></person-group><article-title>Heart failure-associated changes in RNA splicing of sarcomere genes</article-title><source><italic>Circulation</italic></source><year>2010</year><volume>3</volume><issue>2</issue><fpage>138</fpage><lpage>146</lpage><pub-id pub-id-type="other">2-s2.0-77953677503</pub-id><pub-id pub-id-type="pmid">20124440</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burkhardt</surname><given-names>R</given-names></name><name><surname>Kenny</surname><given-names>EE</given-names></name><name><surname>Lowe</surname><given-names>JK</given-names></name><etal/></person-group><article-title>Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13</article-title><source><italic>Arteriosclerosis, Thrombosis, and Vascular Biology</italic></source><year>2008</year><volume>28</volume><issue>11</issue><fpage>2078</fpage><lpage>2084</lpage><pub-id pub-id-type="other">2-s2.0-55449105227</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Tucker</surname><given-names>HM</given-names></name><name><surname>Grear</surname><given-names>KE</given-names></name><etal/></person-group><article-title>A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol</article-title><source><italic>Human Molecular Genetics</italic></source><year>2007</year><volume>16</volume><issue>14</issue><fpage>1765</fpage><lpage>1772</lpage><pub-id pub-id-type="other">2-s2.0-34547793131</pub-id><pub-id pub-id-type="pmid">17517690</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>RJ</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><etal/></person-group><article-title>A novel splicing variant of proprotein convertase subtilisin/kexin type 9</article-title><source><italic>DNA and Cell Biology</italic></source><year>2008</year><volume>27</volume><issue>4</issue><fpage>183</fpage><lpage>189</lpage><pub-id pub-id-type="other">2-s2.0-42149196014</pub-id><pub-id pub-id-type="pmid">18052825</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gil</surname><given-names>G</given-names></name><name><surname>Smith</surname><given-names>JR</given-names></name><name><surname>Goldstein</surname><given-names>JL</given-names></name><name><surname>Brown</surname><given-names>MS</given-names></name></person-group><article-title>Optional exon in the 5&#x02032;-untranslated region of 3-hydroxy-3-methylglutaryl coenzyme A synthase gene: conserved sequence and splicing pattern in humans and hamsters</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1987</year><volume>84</volume><issue>7</issue><fpage>1863</fpage><lpage>1866</lpage><pub-id pub-id-type="other">2-s2.0-0023136487</pub-id><pub-id pub-id-type="pmid">3470763</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Houten</surname><given-names>SM</given-names></name><name><surname>Koster</surname><given-names>J</given-names></name><name><surname>Romeijn</surname><given-names>GJ</given-names></name><etal/></person-group><article-title>Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome</article-title><source><italic>European Journal of Human Genetics</italic></source><year>2001</year><volume>9</volume><issue>4</issue><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="other">2-s2.0-0035063676</pub-id><pub-id pub-id-type="pmid">11313768</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaida</surname><given-names>D</given-names></name><name><surname>Schneider-Poetsch</surname><given-names>T</given-names></name><name><surname>Yoshida</surname><given-names>M</given-names></name></person-group><article-title>Splicing in oncogenesis and tumor suppression</article-title><source><italic>Cancer Science</italic></source><year>2012</year><volume>103</volume><issue>9</issue><fpage>1611</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">22691055</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagen</surname><given-names>RM</given-names></name><name><surname>Ladomery</surname><given-names>MR</given-names></name></person-group><article-title>Role of splice variants in the metastatic progression of prostate cancer</article-title><source><italic>Biochemical Society Transactions</italic></source><year>2012</year><volume>40</volume><issue>4</issue><fpage>870</fpage><lpage>874</lpage><pub-id pub-id-type="pmid">22817750</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampath</surname><given-names>J</given-names></name><name><surname>Pelus</surname><given-names>LM</given-names></name></person-group><article-title>Alternative splice variants of survivin as potential targets in cancer</article-title><source><italic>Current Drug Discovery Technologies</italic></source><year>2007</year><volume>4</volume><issue>3</issue><fpage>174</fpage><lpage>191</lpage><pub-id pub-id-type="other">2-s2.0-36448944759</pub-id><pub-id pub-id-type="pmid">17986000</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Fujibuchi</surname><given-names>W</given-names></name><name><surname>Sasaki</surname><given-names>I</given-names></name></person-group><article-title>Alternative pre-mRNA splicing in digestive tract malignancy</article-title><source><italic>Cancer Science</italic></source><year>2011</year><volume>102</volume><issue>2</issue><fpage>309</fpage><lpage>316</lpage><pub-id pub-id-type="other">2-s2.0-79952081852</pub-id><pub-id pub-id-type="pmid">21134075</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okumura</surname><given-names>N</given-names></name><name><surname>Yoshida</surname><given-names>H</given-names></name><name><surname>Kitagishi</surname><given-names>Y</given-names></name><name><surname>Nishimura</surname><given-names>Y</given-names></name><name><surname>Matsuda</surname><given-names>S</given-names></name></person-group><article-title>Alternative splicings on p53, BRCA1 and PTEN genes involved in breast cancer</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2011</year><volume>413</volume><issue>3</issue><fpage>395</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">21893034</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talieri</surname><given-names>M</given-names></name><name><surname>Devetzi</surname><given-names>M</given-names></name><name><surname>Scorilas</surname><given-names>A</given-names></name><etal/></person-group><article-title>Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact</article-title><source><italic>Tumor Biology</italic></source><year>2012</year><volume>33</volume><issue>4</issue><fpage>1075</fpage><lpage>1084</lpage><pub-id pub-id-type="pmid">22351561</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tammaro</surname><given-names>C</given-names></name><name><surname>Raponi</surname><given-names>M</given-names></name><name><surname>Wilson</surname><given-names>DI</given-names></name><name><surname>Baralle</surname><given-names>D</given-names></name></person-group><article-title>BRCA1 exon 11 alternative splicing, multiple functions and the association with cancer</article-title><source><italic>Biochemical Society Transactions</italic></source><year>2012</year><volume>40</volume><issue>4</issue><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">22817731</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>RX</given-names></name><name><surname>Zu</surname><given-names>XY</given-names></name><etal/></person-group><article-title>Identification and characterization of novel spliced variants of PRMT2 in breast carcinoma</article-title><source><italic>FEBS Journal</italic></source><year>2012</year><volume>279</volume><issue>2</issue><fpage>316</fpage><lpage>335</lpage><pub-id pub-id-type="pmid">22093364</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>H</given-names></name><name><surname>Santos</surname><given-names>S</given-names></name><name><surname>Battaglia</surname><given-names>E</given-names></name><name><surname>Brito</surname><given-names>M</given-names></name><name><surname>Monteiro</surname><given-names>C</given-names></name><name><surname>Bagrel</surname><given-names>D</given-names></name></person-group><article-title>Differential expression of CDC25 phosphatases splice variants in human breast cancer cells</article-title><source><italic>Clinical Chemistry and Laboratory Medicine</italic></source><year>2011</year><volume>49</volume><issue>10</issue><fpage>1707</fpage><lpage>1714</lpage><pub-id pub-id-type="pmid">21675940</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sebban</surname><given-names>S</given-names></name><name><surname>Golan-Gerstl</surname><given-names>R</given-names></name><name><surname>Karni</surname><given-names>R</given-names></name><name><surname>Vaksman</surname><given-names>O</given-names></name><name><surname>Davidson</surname><given-names>B</given-names></name><name><surname>Reich</surname><given-names>R</given-names></name></person-group><article-title>Alternatively spliced lysyl oxidase-like 4 isoforms have a pro-metastatic role in cancer</article-title><source><italic>Clinical and Experimental Metastasis</italic></source><year>2013</year><volume>30</volume><issue>1</issue><fpage>103</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">22806361</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Chan</surname><given-names>DW</given-names></name><name><surname>Liu</surname><given-names>VWS</given-names></name><name><surname>Chiu</surname><given-names>PM</given-names></name><name><surname>Ngan</surname><given-names>HYS</given-names></name></person-group><article-title>Differential functions of growth factor receptor-bound protein 7 (GRB7) and its variant GRB7v in ovarian carcinogenesis</article-title><source><italic>Clinical Cancer Research</italic></source><year>2010</year><volume>16</volume><issue>9</issue><fpage>2529</fpage><lpage>2539</lpage><pub-id pub-id-type="other">2-s2.0-77951758017</pub-id><pub-id pub-id-type="pmid">20388850</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haile</surname><given-names>S</given-names></name><name><surname>Sadar</surname><given-names>MD</given-names></name></person-group><article-title>Androgen receptor and its splice variants in prostate cancer</article-title><source><italic>Cellular and Molecular Life Sciences</italic></source><year>2011</year><volume>68</volume><issue>24</issue><fpage>3971</fpage><lpage>3981</lpage><pub-id pub-id-type="pmid">21748469</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usher</surname><given-names>PA</given-names></name><name><surname>Sieuwerts</surname><given-names>AM</given-names></name><name><surname>Bartels</surname><given-names>A</given-names></name><etal/></person-group><article-title>Identification of alternatively spliced TIMP-1 mRNA in cancer cell lines and colon cancer tissue</article-title><source><italic>Molecular Oncology</italic></source><year>2007</year><volume>1</volume><issue>2</issue><fpage>205</fpage><lpage>215</lpage><pub-id pub-id-type="other">2-s2.0-34547573074</pub-id><pub-id pub-id-type="pmid">19383295</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gotley</surname><given-names>DC</given-names></name><name><surname>Fawcett</surname><given-names>J</given-names></name><name><surname>Walsh</surname><given-names>MD</given-names></name><name><surname>Reeder</surname><given-names>JA</given-names></name><name><surname>Simmons</surname><given-names>DL</given-names></name><name><surname>Antalis</surname><given-names>TM</given-names></name></person-group><article-title>Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer</article-title><source><italic>British Journal of Cancer</italic></source><year>1996</year><volume>74</volume><issue>3</issue><fpage>342</fpage><lpage>351</lpage><pub-id pub-id-type="other">2-s2.0-0030055727</pub-id><pub-id pub-id-type="pmid">8695347</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pio</surname><given-names>R</given-names></name><name><surname>Montuenga</surname><given-names>LM</given-names></name></person-group><article-title>Alternative splicing in lung cancer</article-title><source><italic>Journal of Thoracic Oncology</italic></source><year>2009</year><volume>4</volume><issue>6</issue><fpage>674</fpage><lpage>678</lpage><pub-id pub-id-type="other">2-s2.0-67849087126</pub-id><pub-id pub-id-type="pmid">19461400</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moretti</surname><given-names>D</given-names></name><name><surname>Del Bello</surname><given-names>B</given-names></name><name><surname>Cosci</surname><given-names>E</given-names></name><name><surname>Biagioli</surname><given-names>M</given-names></name><name><surname>Miracco</surname><given-names>C</given-names></name><name><surname>Maellaro</surname><given-names>E</given-names></name></person-group><article-title>Novel variants of muscle calpain 3 identified in human melanoma cells: cisplatin-induced changes in vitro and differential expression in melanocytic lesions</article-title><source><italic>Carcinogenesis</italic></source><year>2009</year><volume>30</volume><issue>6</issue><fpage>960</fpage><lpage>967</lpage><pub-id pub-id-type="other">2-s2.0-66749173427</pub-id><pub-id pub-id-type="pmid">19386580</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanoun</surname><given-names>N</given-names></name><name><surname>Bureau</surname><given-names>C</given-names></name><name><surname>Diab</surname><given-names>T</given-names></name><etal/></person-group><article-title>The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions</article-title><source><italic>Journal of Hepatology</italic></source><year>2010</year><volume>53</volume><issue>5</issue><fpage>880</fpage><lpage>888</lpage><pub-id pub-id-type="other">2-s2.0-77957326321</pub-id><pub-id pub-id-type="pmid">20801538</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>Q</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name></person-group><article-title>Alternative spliced variants as biomarkers of colorectal cancer</article-title><source><italic>Current Drug Metabolism</italic></source><year>2011</year><volume>12</volume><issue>10</issue><fpage>966</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">21787266</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omenn</surname><given-names>GS</given-names></name><name><surname>Yocum</surname><given-names>AK</given-names></name><name><surname>Menon</surname><given-names>R</given-names></name></person-group><article-title>Alternative splice variants, a new class of protein cancer biomarker candidates: findings in pancreatic cancer and breast cancer with systems biology implications</article-title><source><italic>Disease Markers</italic></source><year>2010</year><volume>28</volume><issue>4</issue><fpage>241</fpage><lpage>251</lpage><pub-id pub-id-type="other">2-s2.0-77954131742</pub-id><pub-id pub-id-type="pmid">20534909</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Gamazon</surname><given-names>ER</given-names></name><name><surname>Rebman</surname><given-names>E</given-names></name><etal/></person-group><article-title>Variants affecting exon skipping contribute to complex traits</article-title><source><italic>PLOS Genetics</italic></source><year>2012</year><volume>8</volume><issue>10</issue><pub-id pub-id-type="publisher-id">e1002998</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname><given-names>H</given-names></name><name><surname>Qin</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name></person-group><article-title>Opportunities and methods for studying alternative splicing in cancer with RNA-Seq</article-title><source><italic>Cancer Letters</italic></source><year>2012</year></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Bahn</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><etal/></person-group><article-title>Identification of allele-specific alternative mRNA processing via transcriptome sequencing</article-title><source><italic>Nucleic Acids Research</italic></source><year>2012</year><volume>40</volume><issue>13, article e104</issue></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xi</surname><given-names>L</given-names></name><name><surname>Feber</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>V</given-names></name><etal/></person-group><article-title>Whole genome exon arrays identify differential expression of alternatively spliced, cancer-related genes in lung cancer</article-title><source><italic>Nucleic Acids Research</italic></source><year>2008</year><volume>36</volume><issue>20</issue><fpage>6535</fpage><lpage>6547</lpage><pub-id pub-id-type="other">2-s2.0-56649083778</pub-id><pub-id pub-id-type="pmid">18927117</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Dov</surname><given-names>C</given-names></name><name><surname>Hartmann</surname><given-names>B</given-names></name><name><surname>Lundgren</surname><given-names>J</given-names></name><name><surname>Valc&#x000e1;rcel</surname><given-names>J</given-names></name></person-group><article-title>Genome-wide analysis of alternative pre-mRNA splicing</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2008</year><volume>283</volume><issue>3</issue><fpage>1229</fpage><lpage>1233</lpage><pub-id pub-id-type="other">2-s2.0-38349132539</pub-id><pub-id pub-id-type="pmid">18024428</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gautschi</surname><given-names>O</given-names></name><name><surname>Ratschiller</surname><given-names>D</given-names></name><name><surname>Gugger</surname><given-names>M</given-names></name><name><surname>Betticher</surname><given-names>DC</given-names></name><name><surname>Heighway</surname><given-names>J</given-names></name></person-group><article-title>Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation</article-title><source><italic>Lung Cancer</italic></source><year>2007</year><volume>55</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="other">2-s2.0-33845951110</pub-id><pub-id pub-id-type="pmid">17070615</pub-id></element-citation></ref><ref id="B51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamolle</surname><given-names>G</given-names></name><name><surname>Marin</surname><given-names>M</given-names></name><name><surname>Alvarez-Valin</surname><given-names>F</given-names></name></person-group><article-title>Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers</article-title><source><italic>Mutation Research</italic></source><year>2006</year><volume>600</volume><issue>1-2</issue><fpage>102</fpage><lpage>112</lpage><pub-id pub-id-type="other">2-s2.0-33747482692</pub-id><pub-id pub-id-type="pmid">16650445</pub-id></element-citation></ref><ref id="B52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neklason</surname><given-names>DW</given-names></name><name><surname>Solomon</surname><given-names>CH</given-names></name><name><surname>Dalton</surname><given-names>AL</given-names></name><name><surname>Kuwada</surname><given-names>SK</given-names></name><name><surname>Burt</surname><given-names>RW</given-names></name></person-group><article-title>Intron 4 mutation in APC gene results in splice defect and attenuated FAP phenotype</article-title><source><italic>Familial Cancer</italic></source><year>2004</year><volume>3</volume><issue>1</issue><fpage>35</fpage><lpage>40</lpage><pub-id pub-id-type="other">2-s2.0-3142698784</pub-id><pub-id pub-id-type="pmid">15131404</pub-id></element-citation></ref><ref id="B53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raponi</surname><given-names>M</given-names></name><name><surname>Kralovicova</surname><given-names>J</given-names></name><name><surname>Copson</surname><given-names>E</given-names></name><etal/></person-group><article-title>Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6</article-title><source><italic>Human Mutation</italic></source><year>2011</year><volume>32</volume><issue>4</issue><fpage>436</fpage><lpage>444</lpage><pub-id pub-id-type="other">2-s2.0-79952755720</pub-id><pub-id pub-id-type="pmid">21309043</pub-id></element-citation></ref><ref id="B54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>HX</given-names></name><name><surname>Cartegni</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>MQ</given-names></name><name><surname>Krainer</surname><given-names>AR</given-names></name></person-group><article-title>A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes</article-title><source><italic>Nature Genetics</italic></source><year>2001</year><volume>27</volume><issue>1</issue><fpage>55</fpage><lpage>58</lpage><pub-id pub-id-type="other">2-s2.0-0035158730</pub-id><pub-id pub-id-type="pmid">11137998</pub-id></element-citation></ref><ref id="B55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narla</surname><given-names>G</given-names></name><name><surname>DiFeo</surname><given-names>A</given-names></name><name><surname>Reeves</surname><given-names>HL</given-names></name><etal/></person-group><article-title>A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk</article-title><source><italic>Cancer Research</italic></source><year>2005</year><volume>65</volume><issue>4</issue><fpage>1213</fpage><lpage>1222</lpage><pub-id pub-id-type="other">2-s2.0-13944252065</pub-id><pub-id pub-id-type="pmid">15735005</pub-id></element-citation></ref><ref id="B56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Narla</surname><given-names>G</given-names></name><name><surname>Difeo</surname><given-names>A</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><etal/></person-group><article-title>Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread</article-title><source><italic>Cancer Research</italic></source><year>2005</year><volume>65</volume><issue>13</issue><fpage>5761</fpage><lpage>5768</lpage><pub-id pub-id-type="other">2-s2.0-21344473196</pub-id><pub-id pub-id-type="pmid">15994951</pub-id></element-citation></ref><ref id="B57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiFeo</surname><given-names>A</given-names></name><name><surname>Feld</surname><given-names>L</given-names></name><name><surname>Rodriguez</surname><given-names>E</given-names></name><etal/></person-group><article-title>A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response</article-title><source><italic>Cancer Research</italic></source><year>2008</year><volume>68</volume><issue>4</issue><fpage>965</fpage><lpage>970</lpage><pub-id pub-id-type="other">2-s2.0-39449090999</pub-id><pub-id pub-id-type="pmid">18250346</pub-id></element-citation></ref><ref id="B58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>JO</given-names></name><name><surname>Kim</surname><given-names>WY</given-names></name><name><surname>Bhak</surname><given-names>J</given-names></name></person-group><article-title>ssSNPTarget: genome-wide splice-site single nucleotide polymorphism database</article-title><source><italic>Human Mutation</italic></source><year>2009</year><volume>30</volume><issue>12</issue><fpage>E1010</fpage><lpage>E1020</lpage><pub-id pub-id-type="other">2-s2.0-71749092105</pub-id><pub-id pub-id-type="pmid">19760752</pub-id></element-citation></ref><ref id="B59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Douglas</surname><given-names>AG</given-names></name><name><surname>Wood</surname><given-names>MJ</given-names></name></person-group><article-title>RNA splicing: disease and therapy</article-title><source><italic>Briefings in Functional Genomics</italic></source><year>2011</year><volume>10</volume><issue>3</issue><fpage>151</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">21628314</pub-id></element-citation></ref><ref id="B60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>RK</given-names></name><name><surname>Cooper</surname><given-names>TA</given-names></name></person-group><article-title>Pre-mRNA splicing in disease and therapeutics</article-title><source><italic>Trends in Molecular Medicine</italic></source><year>2012</year><volume>18</volume><issue>8</issue><fpage>472</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">22819011</pub-id></element-citation></ref><ref id="B61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spitali</surname><given-names>P</given-names></name><name><surname>Aartsma-Rus</surname><given-names>A</given-names></name></person-group><article-title>Splice modulating therapies for human disease</article-title><source><italic>Cell</italic></source><year>2012</year><volume>148</volume><issue>6</issue><fpage>1085</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">22424220</pub-id></element-citation></ref><ref id="B62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Fujibuchi</surname><given-names>W</given-names></name><name><surname>Unno</surname><given-names>M</given-names></name></person-group><article-title>Splice isoforms as therapeutic targets for colorectal cancer</article-title><source><italic>Carcinogenesis</italic></source><year>2012</year><volume>33</volume><issue>12</issue><fpage>2311</fpage><lpage>2319</lpage><pub-id pub-id-type="pmid">23118106</pub-id></element-citation></ref><ref id="B63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maciejewski</surname><given-names>JP</given-names></name><name><surname>Padgett</surname><given-names>RA</given-names></name></person-group><article-title>Defects in spliceosomal machinery: a new pathway of leukaemogenesis</article-title><source><italic>British Journal of Haematology</italic></source><year>2012</year><volume>158</volume><issue>2</issue><fpage>165</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">22594801</pub-id></element-citation></ref><ref id="B64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagiwara</surname><given-names>M</given-names></name></person-group><article-title>Alternative splicing: a new drug target of the post-genome era</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2005</year><volume>1754</volume><issue>1-2</issue><fpage>324</fpage><lpage>331</lpage><pub-id pub-id-type="other">2-s2.0-29144463738</pub-id><pub-id pub-id-type="pmid">16260193</pub-id></element-citation></ref><ref id="B65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>CA</given-names></name><name><surname>Zi</surname><given-names>X</given-names></name></person-group><article-title>Potential molecular targeting of splice variants for cancer treatment</article-title><source><italic>Indian Journal of Experimental Biology</italic></source><year>2011</year><volume>49</volume><issue>11</issue><fpage>836</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">22126014</pub-id></element-citation></ref><ref id="B66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Alphen</surname><given-names>RJ</given-names></name><name><surname>Wiemer</surname><given-names>EAC</given-names></name><name><surname>Burger</surname><given-names>H</given-names></name><name><surname>Eskens</surname><given-names>FALM</given-names></name></person-group><article-title>The spliceosome as target for anticancer treatment</article-title><source><italic>British Journal of Cancer</italic></source><year>2009</year><volume>100</volume><issue>2</issue><fpage>228</fpage><lpage>232</lpage><pub-id pub-id-type="other">2-s2.0-58749105294</pub-id><pub-id pub-id-type="pmid">19034274</pub-id></element-citation></ref><ref id="B67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnal</surname><given-names>S</given-names></name><name><surname>Vigevani</surname><given-names>L</given-names></name><name><surname>Valcarcel</surname><given-names>J</given-names></name></person-group><article-title>The spliceosome as a target of novel antitumour drugs</article-title><source><italic>Nature Reviews Drug Discovery</italic></source><year>2012</year><volume>11</volume><issue>11</issue><fpage>847</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">23123942</pub-id></element-citation></ref><ref id="B68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrie</surname><given-names>ES</given-names></name><name><surname>Smith</surname><given-names>RM</given-names></name><name><surname>Sanford</surname><given-names>JC</given-names></name><name><surname>Sadee</surname><given-names>W</given-names></name></person-group><article-title>mRNA transcript diversity creates new opportunities for pharmacological intervention</article-title><source><italic>Molecular Pharmacology</italic></source><year>2012</year><volume>81</volume><issue>5</issue><fpage>620</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">22319206</pub-id></element-citation></ref><ref id="B69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>ML</given-names></name><name><surname>Lorson</surname><given-names>CL</given-names></name><name><surname>Androphy</surname><given-names>EJ</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name></person-group><article-title>An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA</article-title><source><italic>Gene Therapy</italic></source><year>2001</year><volume>8</volume><issue>20</issue><fpage>1532</fpage><lpage>1538</lpage><pub-id pub-id-type="other">2-s2.0-0035158371</pub-id><pub-id pub-id-type="pmid">11704813</pub-id></element-citation></ref><ref id="B70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreassi</surname><given-names>C</given-names></name><name><surname>Jarecki</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients</article-title><source><italic>Human Molecular Genetics</italic></source><year>2001</year><volume>10</volume><issue>24</issue><fpage>2841</fpage><lpage>2849</lpage><pub-id pub-id-type="other">2-s2.0-0035891862</pub-id><pub-id pub-id-type="pmid">11734549</pub-id></element-citation></ref><ref id="B71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lunn</surname><given-names>MR</given-names></name><name><surname>Root</surname><given-names>DE</given-names></name><name><surname>Martino</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Indoprofen upregulates the survival motor neuron protein through a cyclooxygenase-independent mechanism</article-title><source><italic>Chemistry and Biology</italic></source><year>2004</year><volume>11</volume><issue>11</issue><fpage>1489</fpage><lpage>1493</lpage><pub-id pub-id-type="other">2-s2.0-8844240017</pub-id><pub-id pub-id-type="pmid">15555999</pub-id></element-citation></ref><ref id="B72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Grzeschik</surname><given-names>SM</given-names></name><name><surname>Ganta</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name></person-group><article-title>Hydroxyurea enhances SMN2 gene expression through nitric oxide release</article-title><source><italic>Neurogenetics</italic></source><year>2011</year><volume>12</volume><issue>1</issue><fpage>19</fpage><lpage>24</lpage><pub-id pub-id-type="other">2-s2.0-79951549405</pub-id><pub-id pub-id-type="pmid">21174137</pub-id></element-citation></ref><ref id="B73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weihl</surname><given-names>CC</given-names></name><name><surname>Connolly</surname><given-names>AM</given-names></name><name><surname>Pestronk</surname><given-names>A</given-names></name></person-group><article-title>Valproate may improve strength and function in patients with type III/IV spinal muscle atrophy</article-title><source><italic>Neurology</italic></source><year>2006</year><volume>67</volume><issue>3</issue><fpage>500</fpage><lpage>501</lpage><pub-id pub-id-type="other">2-s2.0-33747083488</pub-id><pub-id pub-id-type="pmid">16775228</pub-id></element-citation></ref><ref id="B74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuo</surname><given-names>CY</given-names></name><name><surname>Lin</surname><given-names>HH</given-names></name><name><surname>Chang</surname><given-names>YS</given-names></name><name><surname>Yang</surname><given-names>WK</given-names></name><name><surname>Chang</surname><given-names>JG</given-names></name></person-group><article-title>5-(N-ethyl-N-isopropyl)-amiloride enhances SMN2 exon 7 inclusion and protein expression in spinal muscular atrophy cells</article-title><source><italic>Annals of Neurology</italic></source><year>2008</year><volume>63</volume><issue>1</issue><fpage>26</fpage><lpage>34</lpage><pub-id pub-id-type="other">2-s2.0-39049125699</pub-id><pub-id pub-id-type="pmid">17924536</pub-id></element-citation></ref><ref id="B75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andreassi</surname><given-names>C</given-names></name><name><surname>Angelozzi</surname><given-names>C</given-names></name><name><surname>Tiziano</surname><given-names>FD</given-names></name><etal/></person-group><article-title>Phenylbutyrate increases SMN expression in vitro: relevance for treatment of spinal muscular atrophy</article-title><source><italic>European Journal of Human Genetics</italic></source><year>2004</year><volume>12</volume><issue>1</issue><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="other">2-s2.0-10744229981</pub-id><pub-id pub-id-type="pmid">14560316</pub-id></element-citation></ref><ref id="B76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Kelemen</surname><given-names>O</given-names></name><name><surname>Van Santen</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Synthesis and characterization of pseudocantharidins, novel phosphatase modulators that promote the inclusion of exon 7 into the SMN (survival of motoneuron) pre-mRNA</article-title><source><italic>Journal of Biological Chemistry</italic></source><year>2011</year><volume>286</volume><issue>12</issue><fpage>10126</fpage><lpage>10136</lpage><pub-id pub-id-type="other">2-s2.0-79953169568</pub-id><pub-id pub-id-type="pmid">21220421</pub-id></element-citation></ref><ref id="B77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harahap</surname><given-names>ISK</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name><name><surname>San</surname><given-names>LP</given-names></name><etal/></person-group><article-title>Valproic acid increases SMN2 expression and modulates SF2/ASF and hnRNPA1 expression in SMA fibroblast cell lines</article-title><source><italic>Brain and Development</italic></source><year>2011</year><pub-id pub-id-type="other">2-s2.0-79955692915</pub-id></element-citation></ref><ref id="B78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Donahue</surname><given-names>CP</given-names></name><name><surname>Wolfe</surname><given-names>MS</given-names></name><name><surname>Varani</surname><given-names>G</given-names></name></person-group><article-title>Structural Basis for Stabilization of the Tau Pre-mRNA Splicing Regulatory Element by Novantrone (Mitoxantrone)</article-title><source><italic>Chemistry and Biology</italic></source><year>2009</year><volume>16</volume><issue>5</issue><fpage>557</fpage><lpage>566</lpage><pub-id pub-id-type="other">2-s2.0-65749105061</pub-id><pub-id pub-id-type="pmid">19477420</pub-id></element-citation></ref><ref id="B79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>JS</given-names></name><name><surname>Jordan</surname><given-names>VC</given-names></name></person-group><article-title>Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance</article-title><source><italic>Mutation Research</italic></source><year>2005</year><volume>591</volume><issue>1-2</issue><fpage>247</fpage><lpage>263</lpage><pub-id pub-id-type="other">2-s2.0-27844511538</pub-id><pub-id pub-id-type="pmid">16083919</pub-id></element-citation></ref><ref id="B80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>SL</given-names></name><name><surname>Yan</surname><given-names>LY</given-names></name><name><surname>Zhang</surname><given-names>XT</given-names></name><etal/></person-group><article-title>ER-<italic>&#x003b1;</italic>36, a variant of ER-<italic>&#x003b1;</italic>, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways</article-title><source><italic>PLoS ONE</italic></source><year>2010</year><volume>5</volume><issue>2</issue><pub-id pub-id-type="other">2-s2.0-77749252827</pub-id><pub-id pub-id-type="publisher-id">e9013</pub-id></element-citation></ref><ref id="B81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaharieva</surname><given-names>E</given-names></name><name><surname>Chipman</surname><given-names>JK</given-names></name><name><surname>Soller</surname><given-names>M</given-names></name></person-group><article-title>Alternative splicing interference by xenobiotics</article-title><source><italic>Toxicology </italic></source><year>2012</year><volume>296</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">22321775</pub-id></element-citation></ref><ref id="B82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaida</surname><given-names>D</given-names></name><name><surname>Motoyoshi</surname><given-names>H</given-names></name><name><surname>Tashiro</surname><given-names>E</given-names></name><etal/></person-group><article-title>Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA</article-title><source><italic>Nature Chemical Biology</italic></source><year>2007</year><volume>3</volume><issue>9</issue><fpage>576</fpage><lpage>583</lpage><pub-id pub-id-type="other">2-s2.0-34548095157</pub-id><pub-id pub-id-type="pmid">17643111</pub-id></element-citation></ref><ref id="B83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kotake</surname><given-names>Y</given-names></name><name><surname>Sagane</surname><given-names>K</given-names></name><name><surname>Owa</surname><given-names>T</given-names></name><etal/></person-group><article-title>Splicing factor SF3b as a target of the antitumor natural product pladienolide</article-title><source><italic>Nature Chemical Biology</italic></source><year>2007</year><volume>3</volume><issue>9</issue><fpage>570</fpage><lpage>575</lpage><pub-id pub-id-type="other">2-s2.0-34548104659</pub-id><pub-id pub-id-type="pmid">17643112</pub-id></element-citation></ref><ref id="B84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname><given-names>L</given-names></name><name><surname>Lagisetti</surname><given-names>C</given-names></name><name><surname>Edwards</surname><given-names>CC</given-names></name><name><surname>Webb</surname><given-names>TR</given-names></name><name><surname>Potter</surname><given-names>PM</given-names></name></person-group><article-title>Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing</article-title><source><italic>ACS Chemical Biology</italic></source><year>2011</year><volume>6</volume><issue>6</issue><fpage>582</fpage><lpage>589</lpage><pub-id pub-id-type="other">2-s2.0-79961049732</pub-id><pub-id pub-id-type="pmid">21344922</pub-id></element-citation></ref><ref id="B85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corrionero</surname><given-names>A</given-names></name><name><surname>Mi&#x000f1;ana</surname><given-names>B</given-names></name><name><surname>Valc&#x000e1;rcel</surname><given-names>J</given-names></name></person-group><article-title>Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A</article-title><source><italic>Genes and Development</italic></source><year>2011</year><volume>25</volume><issue>5</issue><fpage>445</fpage><lpage>459</lpage><pub-id pub-id-type="other">2-s2.0-79952220808</pub-id><pub-id pub-id-type="pmid">21363963</pub-id></element-citation></ref><ref id="B86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furumai</surname><given-names>R</given-names></name><name><surname>Uchida</surname><given-names>K</given-names></name><name><surname>Komi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF</article-title><source><italic>Cancer Science</italic></source><year>2010</year><volume>101</volume><issue>11</issue><fpage>2483</fpage><lpage>2489</lpage><pub-id pub-id-type="other">2-s2.0-78049422746</pub-id><pub-id pub-id-type="pmid">20726856</pub-id></element-citation></ref><ref id="B87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakajima</surname><given-names>H</given-names></name><name><surname>Sato</surname><given-names>B</given-names></name><name><surname>Fujita</surname><given-names>T</given-names></name><name><surname>Takase</surname><given-names>S</given-names></name><name><surname>Terano</surname><given-names>H</given-names></name><name><surname>Okuhara</surname><given-names>M</given-names></name></person-group><article-title>New antitumor substances, FR901463, FR901464 and FR901465: I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activities</article-title><source><italic>Journal of Antibiotics</italic></source><year>1996</year><volume>49</volume><issue>12</issue><fpage>1196</fpage><lpage>1203</lpage><pub-id pub-id-type="other">2-s2.0-0030461311</pub-id><pub-id pub-id-type="pmid">9031664</pub-id></element-citation></ref><ref id="B88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albert</surname><given-names>BJ</given-names></name><name><surname>McPherson</surname><given-names>PA</given-names></name><name><surname>O&#x02019;Brien</surname><given-names>K</given-names></name><etal/></person-group><article-title>Meayamycin inhibits pre-messenger RNA splicing and exhibits picomolar activity against multidrug-resistant cells</article-title><source><italic>Molecular Cancer Therapeutics</italic></source><year>2009</year><volume>8</volume><issue>8</issue><fpage>2308</fpage><lpage>2318</lpage><pub-id pub-id-type="other">2-s2.0-68849084041</pub-id><pub-id pub-id-type="pmid">19671752</pub-id></element-citation></ref><ref id="B89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolard</surname><given-names>J</given-names></name><name><surname>Vousden</surname><given-names>W</given-names></name><name><surname>Moss</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms</article-title><source><italic>Chemical Science</italic></source><year>2011</year><volume>2011</volume><issue>2</issue><fpage>273</fpage><lpage>278</lpage><pub-id pub-id-type="pmid">22822423</pub-id></element-citation></ref><ref id="B90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamim</surname><given-names>U</given-names></name><name><surname>Hanif</surname><given-names>S</given-names></name><name><surname>Albanyan</surname><given-names>A</given-names></name><etal/></person-group><article-title>Resveratrol-induced apoptosis is enhanced in low pH environments associated with cancer</article-title><source><italic>Journal of Cellular Physiology</italic></source><year>2012</year><volume>227</volume><issue>4</issue><fpage>1493</fpage><lpage>1500</lpage><pub-id pub-id-type="pmid">21678400</pub-id></element-citation></ref><ref id="B91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakubikova</surname><given-names>J</given-names></name><name><surname>Cervi</surname><given-names>D</given-names></name><name><surname>Ooi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma</article-title><source><italic>Haematologica</italic></source><year>2011</year><volume>96</volume><issue>8</issue><fpage>1170</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">21712538</pub-id></element-citation></ref><ref id="B92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markus</surname><given-names>MA</given-names></name><name><surname>Marques</surname><given-names>FZ</given-names></name><name><surname>Morris</surname><given-names>BJ</given-names></name></person-group><article-title>Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs</article-title><source><italic>PLoS One</italic></source><year>2011</year><volume>6</volume><issue>12</issue><pub-id pub-id-type="publisher-id">e28926</pub-id></element-citation></ref><ref id="B93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>K</given-names></name><name><surname>Fujibuchi</surname><given-names>W</given-names></name><name><surname>Unno</surname><given-names>M</given-names></name></person-group><article-title>Splice variants in apoptotic pathway</article-title><source><italic>Experimental Oncology</italic></source><year>2012</year><volume>34</volume><issue>3</issue><fpage>212</fpage><lpage>217</lpage><pub-id pub-id-type="pmid">23070006</pub-id></element-citation></ref><ref id="B94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwerk</surname><given-names>C</given-names></name><name><surname>Schulze-Osthoff</surname><given-names>K</given-names></name></person-group><article-title>Regulation of apoptosis by alternative pre-mRNA splicing</article-title><source><italic>Molecular Cell</italic></source><year>2005</year><volume>19</volume><issue>1</issue><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="other">2-s2.0-21244439380</pub-id><pub-id pub-id-type="pmid">15989960</pub-id></element-citation></ref><ref id="B95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shkreta</surname><given-names>L</given-names></name><name><surname>Froehlich</surname><given-names>U</given-names></name><name><surname>Paquet</surname><given-names>ER</given-names></name><name><surname>Toutant</surname><given-names>J</given-names></name><name><surname>Elela</surname><given-names>SA</given-names></name><name><surname>Chabot</surname><given-names>B</given-names></name></person-group><article-title>Anticancer drugs affect the alternative splicing of Bcl-x and other human apoptotic genes</article-title><source><italic>Molecular Cancer Therapeutics</italic></source><year>2008</year><volume>7</volume><issue>6</issue><fpage>1398</fpage><lpage>1409</lpage><pub-id pub-id-type="other">2-s2.0-49849102216</pub-id><pub-id pub-id-type="pmid">18566212</pub-id></element-citation></ref><ref id="B96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><etal/></person-group><article-title>Identification of a novel cis-element that regulates alternative splicing of Bcl-x pre-mRNA</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2012</year><volume>420</volume><issue>2</issue><fpage>467</fpage><lpage>472</lpage><pub-id pub-id-type="pmid">22440396</pub-id></element-citation></ref><ref id="B97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revil</surname><given-names>T</given-names></name><name><surname>Toutant</surname><given-names>J</given-names></name><name><surname>Shkreta</surname><given-names>L</given-names></name><name><surname>Garneau</surname><given-names>D</given-names></name><name><surname>Cloutier</surname><given-names>P</given-names></name><name><surname>Chabot</surname><given-names>B</given-names></name></person-group><article-title>Protein kinase C-dependent control of Bcl-x alternative splicing</article-title><source><italic>Molecular and Cellular Biology</italic></source><year>2007</year><volume>27</volume><issue>24</issue><fpage>8431</fpage><lpage>8441</lpage><pub-id pub-id-type="other">2-s2.0-37149014737</pub-id><pub-id pub-id-type="pmid">17923691</pub-id></element-citation></ref><ref id="B98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shultz</surname><given-names>JC</given-names></name><name><surname>Goehe</surname><given-names>RW</given-names></name><name><surname>Wijesinghe</surname><given-names>DS</given-names></name><etal/></person-group><article-title>Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a</article-title><source><italic>Cancer Research</italic></source><year>2010</year><volume>70</volume><issue>22</issue><fpage>9185</fpage><lpage>9196</lpage><pub-id pub-id-type="other">2-s2.0-78549234102</pub-id><pub-id pub-id-type="pmid">21045158</pub-id></element-citation></ref><ref id="B99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puppin</surname><given-names>C</given-names></name><name><surname>Passon</surname><given-names>N</given-names></name><name><surname>Franzoni</surname><given-names>A</given-names></name><name><surname>Russo</surname><given-names>D</given-names></name><name><surname>Damante</surname><given-names>G</given-names></name></person-group><article-title>Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells</article-title><source><italic>Oncology Reports</italic></source><year>2011</year><volume>25</volume><issue>2</issue><fpage>393</fpage><lpage>397</lpage><pub-id pub-id-type="other">2-s2.0-78651372726</pub-id><pub-id pub-id-type="pmid">21152868</pub-id></element-citation></ref><ref id="B100"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>RW</given-names></name></person-group><article-title>Alternative splicing regulated by butyrate in bovine epithelial cells</article-title><source><italic>PLoS One</italic></source><year>2012</year><volume>7</volume><issue>6</issue><pub-id pub-id-type="publisher-id">e39182</pub-id></element-citation></ref><ref id="B101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name></person-group><article-title>Bioinformatics analysis of alternative splicing</article-title><source><italic>Briefings in Bioinformatics</italic></source><year>2005</year><volume>6</volume><issue>1</issue><fpage>23</fpage><lpage>33</lpage><pub-id pub-id-type="other">2-s2.0-17244377195</pub-id><pub-id pub-id-type="pmid">15826354</pub-id></element-citation></ref><ref id="B102"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Florea</surname><given-names>LD</given-names></name></person-group><article-title>Bioinformatics of alternative splicing and its regulation</article-title><source><italic>Briefings in Bioinformatics</italic></source><year>2006</year><volume>7</volume><issue>1</issue><fpage>55</fpage><lpage>69</lpage><pub-id pub-id-type="other">2-s2.0-33748770921</pub-id><pub-id pub-id-type="pmid">16761365</pub-id></element-citation></ref><ref id="B103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name></person-group><article-title>Bioinformatics detection of alternative splicing</article-title><source><italic>Methods in Molecular Biology</italic></source><year>2008</year><volume>452</volume><fpage>179</fpage><lpage>197</lpage><pub-id pub-id-type="other">2-s2.0-46449127795</pub-id><pub-id pub-id-type="pmid">18566765</pub-id></element-citation></ref><ref id="B104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Wen</surname><given-names>F</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>AsMamDB: an alternative splice database of mammals</article-title><source><italic>Nucleic Acids Research</italic></source><year>2001</year><volume>29</volume><issue>1</issue><fpage>260</fpage><lpage>263</lpage><pub-id pub-id-type="other">2-s2.0-0035175280</pub-id><pub-id pub-id-type="pmid">11125106</pub-id></element-citation></ref><ref id="B105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>YT</given-names></name><name><surname>Lai</surname><given-names>JJ</given-names></name><name><surname>Yang</surname><given-names>ST</given-names></name><name><surname>Yang</surname><given-names>UC</given-names></name></person-group><article-title>PALS db: putative alternative splicing database</article-title><source><italic>Nucleic Acids Research</italic></source><year>2002</year><volume>30</volume><issue>1</issue><fpage>186</fpage><lpage>190</lpage><pub-id pub-id-type="other">2-s2.0-0036081021</pub-id><pub-id pub-id-type="pmid">11752289</pub-id></element-citation></ref><ref id="B108"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Atanelov</surname><given-names>L</given-names></name><name><surname>Modrek</surname><given-names>B</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name></person-group><article-title>ASAP: the alternative splicing annotation project</article-title><source><italic>Nucleic Acids Research</italic></source><year>2003</year><volume>31</volume><issue>1</issue><fpage>101</fpage><lpage>105</lpage><pub-id pub-id-type="other">2-s2.0-0037246718</pub-id><pub-id pub-id-type="pmid">12519958</pub-id></element-citation></ref><ref id="B106"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pospisil</surname><given-names>H</given-names></name><name><surname>Herrmann</surname><given-names>A</given-names></name><name><surname>Bortfeldt</surname><given-names>RH</given-names></name><name><surname>Reich</surname><given-names>JG</given-names></name></person-group><article-title>EASED: Extended Alternatively Spliced EST Database</article-title><source><italic>Nucleic Acids Research</italic></source><year>2004</year><volume>32</volume><fpage>D70</fpage><lpage>D74</lpage><pub-id pub-id-type="other">2-s2.0-0347899426</pub-id><pub-id pub-id-type="pmid">14681361</pub-id></element-citation></ref><ref id="B107"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsu</surname><given-names>FR</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Lin</surname><given-names>YL</given-names></name><etal/></person-group><article-title>AVATAR: a database for genome-wide alternative splicing event detection using large scale ESTs and mRNAs</article-title><source><italic>, Bioinformation</italic></source><year>2005</year><volume>1</volume><issue>1</issue><fpage>16</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">17597845</pub-id></element-citation></ref><ref id="B109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>CL</given-names></name><name><surname>Kwon</surname><given-names>YS</given-names></name><name><surname>Hai-Ri</surname><given-names>LI</given-names></name><etal/></person-group><article-title>MAASE: an alternative splicing database designed for supporting splicing microarray applications</article-title><source><italic>RNA</italic></source><year>2005</year><volume>11</volume><issue>12</issue><fpage>1767</fpage><lpage>1776</lpage><pub-id pub-id-type="other">2-s2.0-28344432224</pub-id><pub-id pub-id-type="pmid">16251387</pub-id></element-citation></ref><ref id="B113"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Recce</surname><given-names>M</given-names></name><name><surname>Tian</surname><given-names>B</given-names></name></person-group><article-title>PolyA_DB: a database for mammalian mRNA polyadenylation</article-title><source><italic>Nucleic Acids Research</italic></source><year>2005</year><volume>33</volume><fpage>D116</fpage><lpage>D120</lpage><pub-id pub-id-type="other">2-s2.0-13444302775</pub-id><pub-id pub-id-type="pmid">15608159</pub-id></element-citation></ref><ref id="B114"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Texier</surname><given-names>V</given-names></name><name><surname>Riethoven</surname><given-names>JJ</given-names></name><name><surname>Kumanduri</surname><given-names>V</given-names></name><etal/></person-group><article-title>AltTrans: transcript pattern variants annotated for both alternative splicing and alternative polyadenylation</article-title><source><italic>BMC Bioinformatics</italic></source><year>2006</year><volume>7</volume><issue>article 169</issue><pub-id pub-id-type="other">2-s2.0-33645808501</pub-id></element-citation></ref><ref id="B116"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostadinov</surname><given-names>R</given-names></name><name><surname>Malhotra</surname><given-names>N</given-names></name><name><surname>Viotti</surname><given-names>M</given-names></name><name><surname>Shine</surname><given-names>R</given-names></name><name><surname>D&#x02019;Antonio</surname><given-names>L</given-names></name><name><surname>Bagga</surname><given-names>P</given-names></name></person-group><article-title>GRSDB: a database of quadruplex forming G-rich sequences in alternatively processed mammalian pre-mRNA sequences</article-title><source><italic>Nucleic Acids Research</italic></source><year>2006</year><volume>34</volume><fpage>D119</fpage><lpage>124</lpage><pub-id pub-id-type="other">2-s2.0-33644877945</pub-id><pub-id pub-id-type="pmid">16381828</pub-id></element-citation></ref><ref id="B117"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holste</surname><given-names>D</given-names></name><name><surname>Huo</surname><given-names>G</given-names></name><name><surname>Tung</surname><given-names>V</given-names></name><name><surname>Burge</surname><given-names>CB</given-names></name></person-group><article-title>HOLLYWOOD: a comparative relational database of alternative splicing</article-title><source><italic>Nucleic Acids Research</italic></source><year>2006</year><volume>34</volume><fpage>D56</fpage><lpage>62</lpage><pub-id pub-id-type="other">2-s2.0-33644877169</pub-id><pub-id pub-id-type="pmid">16381932</pub-id></element-citation></ref><ref id="B118"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stamm</surname><given-names>S</given-names></name><name><surname>Riethoven</surname><given-names>JJ</given-names></name><name><surname>Le Texier</surname><given-names>V</given-names></name><etal/></person-group><article-title>ASD: a bioinformatics resource on alternative splicing</article-title><source><italic>Nucleic Acids Research</italic></source><year>2006</year><volume>34</volume><fpage>D46</fpage><lpage>55</lpage><pub-id pub-id-type="other">2-s2.0-33644878582</pub-id><pub-id pub-id-type="pmid">16381912</pub-id></element-citation></ref><ref id="B110"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambaldi</surname><given-names>D</given-names></name><name><surname>Felice</surname><given-names>B</given-names></name><name><surname>Praz</surname><given-names>V</given-names></name><name><surname>Bucher</surname><given-names>P</given-names></name><name><surname>Cittaro</surname><given-names>D</given-names></name><name><surname>Guffanti</surname><given-names>A</given-names></name></person-group><article-title>Splicy: a web-based tool for the prediction of possible alternative splicing events from Affymetrix probeset data</article-title><source><italic>BMC Bioinformatics</italic></source><year>2007</year><volume>8</volume><issue>1, article no. S17</issue><pub-id pub-id-type="other">2-s2.0-34248140047</pub-id></element-citation></ref><ref id="B111"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foissac</surname><given-names>S</given-names></name><name><surname>Sammeth</surname><given-names>M</given-names></name></person-group><article-title>ASTALAVISTA: dynamic and flexible analysis of alternative splicing events in custom gene datasets</article-title><source><italic>Nucleic Acids Research</italic></source><year>2007</year><volume>35</volume><fpage>W297</fpage><lpage>299</lpage><pub-id pub-id-type="other">2-s2.0-34547599504</pub-id><pub-id pub-id-type="pmid">17485470</pub-id></element-citation></ref><ref id="B119"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lacroix</surname><given-names>Z</given-names></name><name><surname>Legendre</surname><given-names>C</given-names></name><name><surname>Raschid</surname><given-names>L</given-names></name><name><surname>Snyder</surname><given-names>B</given-names></name></person-group><article-title>BIPASS: BioInformatics Pipeline Alternative Splicing Services</article-title><source><italic>Nucleic Acids Research</italic></source><year>2007</year><volume>35</volume><fpage>W292</fpage><lpage>296</lpage><pub-id pub-id-type="other">2-s2.0-34547602471</pub-id><pub-id pub-id-type="pmid">17584795</pub-id></element-citation></ref><ref id="B120"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><etal/></person-group><article-title>ECgene: an alternative splicing database update</article-title><source><italic>Nucleic Acids Research</italic></source><year>2007</year><volume>35</volume><issue>1</issue><fpage>D99</fpage><lpage>D103</lpage><pub-id pub-id-type="other">2-s2.0-33846039709</pub-id><pub-id pub-id-type="pmid">17132829</pub-id></element-citation></ref><ref id="B126"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhasi</surname><given-names>A</given-names></name><name><surname>Pandey</surname><given-names>RV</given-names></name><name><surname>Utharasamy</surname><given-names>SP</given-names></name><name><surname>Senapathy</surname><given-names>P</given-names></name></person-group><article-title>EuSplice: a unified resource for the analysis of splice signals and alternative splicing in eukaryotic genes</article-title><source><italic>Bioinformatics</italic></source><year>2007</year><volume>23</volume><issue>14</issue><fpage>1815</fpage><lpage>1823</lpage><pub-id pub-id-type="other">2-s2.0-34547869583</pub-id><pub-id pub-id-type="pmid">17344236</pub-id></element-citation></ref><ref id="B112"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ryan</surname><given-names>MC</given-names></name><name><surname>Zeeberg</surname><given-names>BR</given-names></name><name><surname>Caplen</surname><given-names>NJ</given-names></name><etal/></person-group><article-title>SpliceCenter: a suite of web-based bioinformatic applications for evaluating the impact of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies</article-title><source><italic>BMC Bioinformatics</italic></source><year>2008</year><volume>9</volume><issue>article 313</issue><pub-id pub-id-type="other">2-s2.0-48549091806</pub-id></element-citation></ref><ref id="B121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castrignan&#x000f2;</surname><given-names>T</given-names></name><name><surname>D&#x02019;Antonio</surname><given-names>M</given-names></name><name><surname>Anselmo</surname><given-names>A</given-names></name><etal/></person-group><article-title>ASPicDB: a database resource for alternative splicing analysis</article-title><source><italic>Bioinformatics</italic></source><year>2008</year><volume>24</volume><issue>10</issue><fpage>1300</fpage><lpage>1304</lpage><pub-id pub-id-type="other">2-s2.0-43349089687</pub-id><pub-id pub-id-type="pmid">18388144</pub-id></element-citation></ref><ref id="B128"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bechtel</surname><given-names>JM</given-names></name><name><surname>Rajesh</surname><given-names>P</given-names></name><name><surname>Ilikchyan</surname><given-names>I</given-names></name><etal/></person-group><article-title>The Alternative Splicing Mutation Database: a hub for investigations of alternative splicing using mutational evidence</article-title><source><italic>BMC Research Notes</italic></source><year>2008</year><volume>1</volume><issue>article 3</issue><pub-id pub-id-type="other">2-s2.0-77949988909</pub-id></element-citation></ref><ref id="B131"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birzele</surname><given-names>F</given-names></name><name><surname>K&#x000fc;ffner</surname><given-names>R</given-names></name><name><surname>Meier</surname><given-names>F</given-names></name><name><surname>Oefinger</surname><given-names>F</given-names></name><name><surname>Potthast</surname><given-names>C</given-names></name><name><surname>Zimmer</surname><given-names>R</given-names></name></person-group><article-title>ProSAS: a database for analyzing alternative splicing in the context of protein structures</article-title><source><italic>Nucleic Acids Research</italic></source><year>2008</year><volume>36</volume><issue>1</issue><fpage>D63</fpage><lpage>D68</lpage><pub-id pub-id-type="other">2-s2.0-38549167437</pub-id><pub-id pub-id-type="pmid">17933774</pub-id></element-citation></ref><ref id="B132"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Floris</surname><given-names>M</given-names></name><name><surname>Orsini</surname><given-names>M</given-names></name><name><surname>Thanaraj</surname><given-names>TA</given-names></name></person-group><article-title>Splice-mediated variants of proteins (SpliVaP)&#x02014;data and characterization of changes in signatures among protein isoforms due to alternative splicing</article-title><source><italic>BMC Genomics</italic></source><year>2008</year><volume>9</volume><issue>article 453</issue><pub-id pub-id-type="other">2-s2.0-54949135764</pub-id></element-citation></ref><ref id="B122"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhasi</surname><given-names>A</given-names></name><name><surname>Philip</surname><given-names>P</given-names></name><name><surname>Sreedharan</surname><given-names>VT</given-names></name><name><surname>Senapathy</surname><given-names>P</given-names></name></person-group><article-title>AspAlt: a tool for inter-database, inter-genomic and user-specific comparative analysis of alternative transcription and alternative splicing in 46 eukaryotes</article-title><source><italic>Genomics</italic></source><year>2009</year><volume>94</volume><issue>1</issue><fpage>48</fpage><lpage>54</lpage><pub-id pub-id-type="other">2-s2.0-67349209837</pub-id><pub-id pub-id-type="pmid">19285128</pub-id></element-citation></ref><ref id="B115"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koscielny</surname><given-names>G</given-names></name><name><surname>Texier</surname><given-names>VL</given-names></name><name><surname>Gopalakrishnan</surname><given-names>C</given-names></name><etal/></person-group><article-title>ASTD: the Alternative Splicing and Transcript Diversity database</article-title><source><italic>Genomics</italic></source><year>2009</year><volume>93</volume><issue>3</issue><fpage>213</fpage><lpage>220</lpage><pub-id pub-id-type="other">2-s2.0-60049093585</pub-id><pub-id pub-id-type="pmid">19059335</pub-id></element-citation></ref><ref id="B127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Lenser</surname><given-names>T</given-names></name><name><surname>Jahn</surname><given-names>N</given-names></name><etal/></person-group><article-title>TassDB2: a comprehensive database of subtle alternative splicing events</article-title><source><italic>BMC Bioinformatics</italic></source><year>2010</year><volume>11</volume><issue>article 216</issue><pub-id pub-id-type="other">2-s2.0-77951594700</pub-id></element-citation></ref><ref id="B123"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>JI</given-names></name><name><surname>Suzuki</surname><given-names>Y</given-names></name><name><surname>Sakate</surname><given-names>R</given-names></name><etal/></person-group><article-title>H-DBAS: Human-transcriptome database for alternative splicing: update 2010</article-title><source><italic>Nucleic Acids Research</italic></source><year>2009</year><volume>38</volume><issue>1</issue><fpage>D86</fpage><lpage>D90</lpage><pub-id pub-id-type="other">2-s2.0-75549090156</pub-id><pub-id pub-id-type="publisher-id">gkp984</pub-id><pub-id pub-id-type="pmid">19969536</pub-id></element-citation></ref><ref id="B124"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kroll</surname><given-names>JE</given-names></name><name><surname>Galante</surname><given-names>PA</given-names></name><name><surname>Ohara</surname><given-names>DT</given-names></name><name><surname>Navarro</surname><given-names>FC</given-names></name><name><surname>Ohno-Machado</surname><given-names>L</given-names></name><name><surname>de Souza</surname><given-names>SJ</given-names></name></person-group><article-title>SPLOOCE: a new portal for the analysis of human splicing variants</article-title><source><italic>RNA Biology</italic></source><year>2012</year><volume>9</volume><issue>11</issue><fpage>1339</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">23064119</pub-id></element-citation></ref><ref id="B125"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez</surname><given-names>JM</given-names></name><name><surname>Maietta</surname><given-names>P</given-names></name><name><surname>Ezkurdia</surname><given-names>I</given-names></name><etal/></person-group><article-title>APPRIS: annotation of principal and alternative splice isoforms</article-title><source><italic>Nucleic Acids Research</italic></source><year>2013</year><volume>41</volume><fpage>110</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">23093607</pub-id></element-citation></ref><ref id="B129"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piva</surname><given-names>F</given-names></name><name><surname>Giulietti</surname><given-names>M</given-names></name><name><surname>Burini</surname><given-names>AB</given-names></name><name><surname>Principato</surname><given-names>G</given-names></name></person-group><article-title>SpliceAid 2: a database of human splicing factors expression data and RNA target motifs</article-title><source><italic>Human Mutation</italic></source><year>2012</year><volume>33</volume><issue>1</issue><fpage>81</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">21922594</pub-id></element-citation></ref><ref id="B130"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wingender</surname><given-names>E</given-names></name><name><surname>Schoeps</surname><given-names>T</given-names></name><name><surname>Donitz</surname><given-names>J</given-names></name></person-group><article-title>TFClass: an expandable hierarchical classification of human transcription factors</article-title><source><italic>Nucleic Acids Research</italic></source><year>2013</year><volume>41</volume><fpage>165</fpage><lpage>170</lpage></element-citation></ref></ref-list></back><floats-group><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>The bioinformatics resources related to alternative splicing (yrs 2001&#x02013;2013)*.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td align="left" rowspan="1" colspan="1">AsMamDB [<xref rid="B104" ref-type="bibr">104</xref>]</td><td align="left" rowspan="1" colspan="1">An alternative splice database of mammals (website is unavailable)</td></tr><tr><td align="left" rowspan="1" colspan="1">PALS db [<xref rid="B105" ref-type="bibr">105</xref>]</td><td align="left" rowspan="1" colspan="1">Putative alternative splicing database</td></tr><tr><td align="left" rowspan="1" colspan="1">ASAP [<xref rid="B108" ref-type="bibr">106</xref>]</td><td align="left" rowspan="1" colspan="1">Alternative splicing annotation project (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.ucla.edu/ASAP/">http://www.bioinformatics.ucla.edu/ASAP/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">EASED [<xref rid="B106" ref-type="bibr">107</xref>]</td><td align="left" rowspan="1" colspan="1">Extended alternatively spliced EST database</td></tr><tr><td align="left" rowspan="1" colspan="1">AVATAR [<xref rid="B107" ref-type="bibr">108</xref>]</td><td align="left" rowspan="1" colspan="1">Database for EST and mRNA</td></tr><tr><td align="left" rowspan="1" colspan="1">MAASE [<xref rid="B109" ref-type="bibr">109</xref>]</td><td align="left" rowspan="1" colspan="1">Alternative splicing database designed for splicing microarray (<ext-link ext-link-type="uri" xlink:href="http://maase.genomics.purdue.edu/">http://maase.genomics.purdue.edu/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">PolyA_DB [<xref rid="B113" ref-type="bibr">110</xref>]</td><td align="left" rowspan="1" colspan="1">Database for mRNA polyadenylation in mammalian</td></tr><tr><td align="left" rowspan="1" colspan="1">AltTrans [<xref rid="B114" ref-type="bibr">111</xref>]</td><td align="left" rowspan="1" colspan="1">Annotation for both alternative splicing and alternative polyadenylation</td></tr><tr><td align="left" rowspan="1" colspan="1">GRSDB [<xref rid="B116" ref-type="bibr">112</xref>]</td><td align="left" rowspan="1" colspan="1">Database of quadruplex forming G-rich sequences in alternative splicing sequences (<ext-link ext-link-type="uri" xlink:href="http://bioinformatics.ramapo.edu/grsdb/">http://bioinformatics.ramapo.edu/grsdb/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">HOLLYWOOD [<xref rid="B117" ref-type="bibr">113</xref>]</td><td align="left" rowspan="1" colspan="1">A comparative relational database of alternative splicing (<ext-link ext-link-type="uri" xlink:href="http://hollywood.mit.edu/">http://hollywood.mit.edu/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">ASD [<xref rid="B118" ref-type="bibr">114</xref>]</td><td align="left" rowspan="1" colspan="1">A bioinformatics resource on alternative splicing</td></tr><tr><td align="left" rowspan="1" colspan="1">Splicy [<xref rid="B110" ref-type="bibr">115</xref>]</td><td align="left" rowspan="1" colspan="1">Prediction of alternative splicing from Affymetrix data</td></tr><tr><td align="left" rowspan="1" colspan="1">ASTALAVISTA [<xref rid="B111" ref-type="bibr">116</xref>]</td><td align="left" rowspan="1" colspan="1">Analysis of alternative splicing for custom datasets (<ext-link ext-link-type="uri" xlink:href="http://genome.imim.es/astalavista/">http://genome.imim.es/astalavista/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">BIPASS [<xref rid="B119" ref-type="bibr">117</xref>]</td><td align="left" rowspan="1" colspan="1">Bioinformatics pipeline alternative splicing services</td></tr><tr><td align="left" rowspan="1" colspan="1">ECgene [<xref rid="B120" ref-type="bibr">118</xref>]</td><td align="left" rowspan="1" colspan="1">Alternative splicing database update (<ext-link ext-link-type="uri" xlink:href="http://genome.ewha.ac.kr/ECgene/">http://genome.ewha.ac.kr/ECgene/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">EuSplice [<xref rid="B126" ref-type="bibr">119</xref>]</td><td align="left" rowspan="1" colspan="1">A resource for splice signals and alternative splicing in eukaryotic genes (<ext-link ext-link-type="uri" xlink:href="http://www.genome.com/products-1/integrated-genomics-resources/eusplice">http://www.genome.com/products-1/integrated-genomics-resources/eusplice</ext-link>)
</td></tr><tr><td align="left" rowspan="1" colspan="1">SpliceCenter [<xref rid="B112" ref-type="bibr">120</xref>]</td><td align="left" rowspan="1" colspan="1">A server for analysis of alternative splicing on RT-PCR, RNAi, microarray, and peptide-based studies (<ext-link ext-link-type="uri" xlink:href="http://discover.nci.nih.gov/splicecenter/">http://discover.nci.nih.gov/splicecenter/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">ASPicDB [<xref rid="B121" ref-type="bibr">121</xref>]</td><td align="left" rowspan="1" colspan="1">Database for alternative splicing analysis (<ext-link ext-link-type="uri" xlink:href="http://www.caspur.it/ASPicDB/">http://www.caspur.it/ASPicDB/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">The alternative splicing mutation database [<xref rid="B128" ref-type="bibr">122</xref>]</td><td align="left" rowspan="1" colspan="1">A hub for analyzing alternative splicing from mutational evidence</td></tr><tr><td align="left" rowspan="1" colspan="1">ProSAS [<xref rid="B131" ref-type="bibr">123</xref>]</td><td align="left" rowspan="1" colspan="1">Database for analyzing alternative splicing in the context of protein structures (<ext-link ext-link-type="uri" xlink:href="http://www.bio.ifi.lmu.de/ProSAS/">http://www.bio.ifi.lmu.de/ProSAS/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">Splice-mediated Variants of Proteins (SpliVaP) [<xref rid="B132" ref-type="bibr">124</xref>]</td><td align="left" rowspan="1" colspan="1">Signatures for protein isoforms due to alternative splicing (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatica.crs4.org/tools/dbs/splivap/">http://www.bioinformatica.crs4.org/tools/dbs/splivap/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">AspAlt [<xref rid="B122" ref-type="bibr">125</xref>]</td><td align="left" rowspan="1" colspan="1">A interdatabase for comparative analysis of alternative transcription and splicing (<ext-link ext-link-type="uri" xlink:href="http://www.genome.com/products-1/integrated-genomics-resources/products-integrated-genomics-resources-igr-aspalt">http://www.genome.com/products-1/integrated-genomics-resources/products-integrated-genomics-resources-igr-aspalt</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">ASTD [<xref rid="B115" ref-type="bibr">126</xref>]</td><td align="left" rowspan="1" colspan="1">Alternative splicing and transcript diversity database</td></tr><tr><td align="left" rowspan="1" colspan="1">TassDB2 [<xref rid="B127" ref-type="bibr">127</xref>]</td><td align="left" rowspan="1" colspan="1">A comprehensive database of subtle alternative splicing (<ext-link ext-link-type="uri" xlink:href="http://www.tassdb.info/">http://www.tassdb.info/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">H-DBAS [<xref rid="B123" ref-type="bibr">128</xref>]</td><td align="left" rowspan="1" colspan="1">Human-transcriptome database for alternative splicing (<ext-link ext-link-type="uri" xlink:href="http://h-invitational.jp/h-dbas/">http://h-invitational.jp/h-dbas/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">SPLOOCE [<xref rid="B124" ref-type="bibr">129</xref>]</td><td align="left" rowspan="1" colspan="1">Analysis server of human splicing variants (<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics-brazil.org/splooce/">http://www.bioinformatics-brazil.org/splooce/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">APPRIS [<xref rid="B125" ref-type="bibr">130</xref>]</td><td align="left" rowspan="1" colspan="1">Annotation of human alternative splice isoforms (<ext-link ext-link-type="uri" xlink:href="http://appris.bioinfo.cnio.es/">http://appris.bioinfo.cnio.es/</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">SpliceAid 2 [<xref rid="B129" ref-type="bibr">131</xref>]</td><td align="left" rowspan="1" colspan="1">Database of human splicing factors expression data and RNA target motifs (<ext-link ext-link-type="uri" xlink:href="http://www.introni.it/spliceaid.html">http://www.introni.it/spliceaid.html</ext-link>)</td></tr><tr><td align="left" rowspan="1" colspan="1">TFClass [<xref rid="B130" ref-type="bibr">132</xref>]</td><td align="left" rowspan="1" colspan="1">Classification of human transcription factors (<ext-link ext-link-type="uri" xlink:href="http://tfclass.bioinf.med.uni-goettingen.de/">http://tfclass.bioinf.med.uni-goettingen.de/</ext-link>)</td></tr></tbody></table><table-wrap-foot><fn><p>&#x02009;*The websites for some resources without function currently are not provided.</p></fn></table-wrap-foot></table-wrap></floats-group></article>